Scientific inquiries have identified piR‐001773 and piR‐017184 as being elevated in prostate cancer specimens, and these molecules are believed to regulate the expression levels of protocadherin 9 (PCDH9) in a posttranscriptional manner, thereby influencing disease pathology [45]. The gene discussed is PCDH9; the disease is prostate carcinoma.